The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Yigal Arnon & Co

1 AZRIELI CENTRE, TEL AVIV 67021, ISRAEL
Tel:
Work +972 3 608 7777
Fax:
Fax +972 3 608 7724
Email:
Web:
www.arnon.co.il
Jerusalem, Tel Aviv, Tel Aviv

Barry Levenfeld

Tel:
Work +972 2 6239200
Email:
Web:
www.arnon.co.il/content/levenfeld
Yigal Arnon & Co

Work Department

Commercial Law, Corporate Finance, High-Tech, Life Sciences, Mergers and Acquisitions, Technology and Transactional IP, Telecommunications.

Position

Barry Levenfeld has represented Israeli and international clients for more than 25 years in a diverse and sophisticated cross-border transactional practice. His experience includes mergers & acquisitions, corporate partnering and joint ventures, and public offerings of securities. He has an extensive M&A practice, representing many of the world’s leading technology companies, as well as a venture capital and private equity practice focusing on fund formation and portfolio investment for Israeli and overseas venture capital funds. He also represents clients in complex intellectual property transactional work, including strategic partnering, licensing, distribution, OEM and marketing agreements. Clients range from technology and life science start-up companies to representation in Israel of major international technology companies.

Career

Barry's clients include prominent international corporations such as Medtronic, Sun Microsystems, Deere & Company, eBay, IBM, Boston Scientific, France Telecom, Oracle Software, PMC-Sierra, Symantec and Polycom. His venture clients include many of the leading names on the Israeli venture capital scene, including Gemini and Vintage Ventures. Barry was selected in the years 2000 through 2014 as a leading Israeli lawyer by Chambers Global in the field of Corporate/M&A, citing his “superb focus” and “top-notch understanding of the interplay between US and Israel securities laws”. PLC’s 2008 Which Lawyer? lists Barry as a highly recommended individual in Corporate/M&A, IT and e-commerce and as a recommended individual in Life Sciences: Corporate and Telecommunications. The Legal 500 states that “Yigal Arnon’s Barry Levenfeld is one of the best known corporate lawyers in Israel, especially for his transactions in the technology sector.” Barry is listed in Best Lawyers under Corporate, M&A and Technology. He was also named as a leading lawyer in 2008 through 2013 in Israel by IFLR 1000. He has the reputation of 'getting the deal done' and is quoted in Chambers Global as a lawyer who "is thought to shine in hi-tech related M&A," and "is experienced in a broad array of heavyweight transactions." It further describes Barry as a "well-regarded transactional lawyer who represents his clients aggressively but intelligently." Barry's main practice areas are: Mergers & Acquisitions, Corporate Finance, Emerging Growth Companies, Life Sciences, IP Transactional Group and Telecommunications. Barry speaks and writes on issues related to computer contracting, venture capital, life sciences and M&A. He contributed the chapters on Israeli law for the Mathew Bender publication International Agency and Distribution Law and for the Sweet & Maxwell publication Data Protection Laws of the World. He is a Senior Lecturer in the Law Faculty of the Hebrew University in Jerusalem in corporate finance, and a member of the Board of Alyn Hospital. He was recently appointed Chairman of the Board of the Israel Union for Environmental Defense, Israel’s leading environmental advocacy group.

Languages

Barry is fluent in English and Hebrew. He resides with his wife and four children in Jerusalem, Israel.

Member

Barry is a member of the New York and Israeli bars.

Education

Barry graduated magna cum laude from Harvard College in 1976 and from Harvard Law School in 1980.

Leisure

Barry is an avid cyclist and has actively organized and participated in Israel’s largest charity bicycle ride, for the Alyn Pediatric and Adolescent Hospital and Rehabilitation Center in Jerusalem.


Israel

Commercial, corporate and M&A

Within: Commercial, corporate and M&A

Yigal Arnon & Co is best known for hi-tech deals, where its corporate team is 'well suited to larger technology companies and growth companies'. In a standout matter, Barry Levenfeld acted for Mexican public company Mexichem in relation to its $1.5bn acquisition of Netafim. Also of note, David Schapiro and Eliran Furman are advising SteadyMed on its reverse triangular merger transaction with United Therapeutics Corporation in aggregate value of approximately $216m. Additionally, Orly Tsioni assisted the shareholders of Brack Capital Properties with its $302m sale of control in the company to Redzone Empire Holding. Also recommended is Barak Platt, who in 2017 was involved in the largest-ever M&A in the Israeli hi-tech space. The practice group was further strengthened in 2019 following its merger with Weinstock-Zecler & Co, which brought to the team Gidon Weinstock and Micki Shapira.

[back to top]

Healthcare and life sciences

Within: Leading individuals

Barry Levenfeld - Yigal Arnon & Co

Within: Healthcare and life sciences

Yigal Arnon & Co brings together a very strong corporate practice and a highly specialised IP team to advise clients in the pharmaceutical, medical device and biotech sectors on a range of IP matters, inbound and outbound licensing, and complex M&A and cross-border investment transactions. Yoheved Novogroder-Shoshan advises FutuRx, a joint venture comprising Johnson & Johnson, Takeda and Orbimed, on pharmaceutical licensing transactions with universities and research institutions worldwide. Novogroder-Shoshan also assisted Alyn Hospital with the establishment of its Innovation Space. Also of note, Barry Levenfeld assisted with the formation of MEDX XELERATOR, a state-sponsored medical devices incubator, and provides the client with ongoing advice regarding commercialisation and arrangements among its partners and investors. Moreover, the firm's corporate team has been involved in a number of cross-border transactions in the biotech and healthcare sectors, which included acting for SteadyMed, the target company, in a reverse triangular merger with United Therapeutics Corporation. Other key figures include Daniel Green and Eli Greenbaum.

[back to top]

Hi-tech and start-ups

Within: Hi-tech and start-ups

Yigal Arnon & Co has developed an impressive reputation in the hi-tech market, where it advises clients ranging from Israeli start-ups to multinational giants on high-profile M&A and investment transactions. One key figure in the department is Barry Levenfeld, who advised Mexichem on the widely publicised $1.5bn acquisition of control in the Israeli drip irrigation technology company Netafim. Additionally, Levenfeld and Ben Sandler acted for IBM Corporation in relation to its acquisition of Israeli start-up Cloudigo. The team also has expertise acting on the side of the start-ups. David Schapiro and Eliran Furman advised Magicjack Vocaltec on the $143m acquisition by Nasdaq-listed B. Riley Financial of the client's entire share capital. Similarly, Barak Platt and Ezra Gross acted for Zooz Mobile, an Israeli e-payment company, in relation to its acquisition by PayU Global. The team has also handled significant M&A deals for Houzz, SteadyMed, and Electronic Arts.

[back to top]

Intellectual property: commercial/transactions

Within: Intellectual property: commercial/transactions

Yigal Arnon & Co has strengths across the spectrum of commercial IP transactions, from domestic and international licensing deals to IP-driven M&A in a huge range of sectors, including fintech, medtech, telecoms and big data. Two key figures in the team are Yoheved Novogroder-Shoshan and Barry Levenfeld, who have assisted FutuRx with a number of commercial agreements, including licensing deals with universities in Germany, the US and South Korea. Novogroder-Shoshan also advised Oculis, a Novartis Venture Fund portfolio company, on licensing agreements with two academic institutions in Iceland. Also recommended is Daniel Green, who is acting for iPharma (Hong Kong), a joint venture formed by BioLineRx and a Chinese investor, in relation to an in-licensing transaction with Boehringer Ingelheim International. The team also has expertise in open source software and semiconductors, and Eli Greenbaum handles a range of commercial IP work for clients such as Autotalks. Further, Greenbaum has advised Minute on commercial IP deals with US sporting bodies, including NFL, MLB, NBA and PGA.

[back to top]


Back to index

Legal Developments by:
Yigal Arnon & Co

Legal Developments in Israel

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • INVESTMENT OPPORTUNITIES FOR HNWIs IN ISRAEL’S HI-TECH ECOSYSTEM

    Accredited investor funding platforms for innovative tech scale-ups offer more choice and without having to commit a large chunk of capital upfront, the risk is diluted.
  • Perhaps the QuadragaCX Story Will Have a Happy Ending

    While there are the aficionados who will say that cryptocurrencies will free us of the chains of the global financial institutions, on the occasions when the world of cryptocurrencies intersects with the world in which most of us live, the news is generally bleak. While you may not know one side of a Bitcoin from the other, you probably know that its value has crashed over the last 13 months, you may even have heard about some of some of the larger cryptohacks (that is computer heists through which digital currencies belonging to investors are stolen from crypto trading exchanges). And over the last week or so, you may have read on mainstream news sites about the death of Gerald Cotton the CEO of Canada’s largest cryptoexchange QuadragaCX. The death of the CEO of a company that few had previously heard of, was news of course, because in his passing he had taken the passwords to the accounts of his customers with him. The result of this being that about $140 million of their money was stuck somewhere between this world and the celestial ether in which Mr. Cotton now resides. Of course, it wasn’t quite told like that. We were fed terms such as “private keys,” lack of “multi-signature protection,” “cold storage wallets” and more readily understandable – “cryptofraud”. Again!
  • Israel Chapter in The Virtual Currency Regulation Review

    Earlier this year, the Israel Tax Authority (ITA) issued two circulars, one on the taxation of digital tokens and the second addressing the taxation of utility tokens in initial coin offerings (ICOs). Additionally, in March, the Israel Securities Authority (ISA) released a detailed interim report by the Committee for the Regulation of Public Offerings of Decentralized Cryptocurrency Coins (Report) (with a follow-up report due to come out around October 2018). Moreover, it is expected that before the end of 2018, legislation will come into force that for the first time will see Israeli primary legislation define virtual currencies as financial assets and mandate licensing for related services, as is later discussed in detail.
  • Spring is coming for real estate registration in Israel

    Israel may be the “Start-up Nation” and a world-renowned center of technological innovation, yet for many years the procedures and conduct of the Israeli Land Registry have been trapped in the past.
  • PLATFORMS FOR HIGH NET WORTH INVESTORS IN ISRAELI HIGH-TECH

    Israeli hi-tech and its sources of funding have grown and diversified tremendously since the bubble burst in 2001 and over the last decade since the height of the financial crisis in 2007-2008.
  • NONDISCRIMINATION IN 5G STANDARDS

    Nondiscrimination has been the neglected stepchild of the FRAND commitment. Patent owners participating in standards organizations typically commit to license their technology on “fair, reasonable, and nondiscriminatory (“FRAND”) terms.”
  • Crash Course on Non-Disclosure Agreements

    Non-disclosure agreements are a crucial, but often overlooked, tool in allowing startup companies to grow, build strategic partnerships and explore new business relationships necessary to develop their product or bring it to market. These agreements are often short (sometimes only a page or two) and lead many founders to forego legal advice to get past this "formality" and begin working with the other party to the NDA. Yet, NDAs are important agreements with potentially far-reaching implications for the protection of a company's confidential information and intellectual property, and mishandling of NDAs can come back to haunt a startup years later.
  • Advocates Eli Greenbaum and Ezra Gross of Yigal Arnon & Co. in The Lawyer Special Report editorial

    An interview-style piece in The Lawyer, Law in Israel: moving beyond tech, quoting Eli Greenbaum and Ezra Gross:
  • Publication of Adv. Adrian Daniel's Commentary in Private Banker International on GDPR & Blockchain

    Publication of Adv. Adrian Daniel's Commentary in Private Banker International on GDPR & Blockchain.
  • Article in MEA Markets on GDPR & Israeli Law

    GDPR & ISRAELI PRIVACY LAW - KEY DIFFERENCES Yoheved Novogroder-Shoshan & Miriam Friedmann of Yigal Arnon & Co. outline the key differences between GDPR & Israeli Privacy Law.  mea_markets_-_gdpr__israeli_law_-_key_differences_14.05.2018